ASSURA PLC - Trading update for the first half ended 30 September 2025

Assura plc
(Incorporated in England and Wales)
(Company Number: 09349441)
LEI number: 21380026T19N2Y52XF72
LSE Share Code: AGR
JSE Share Code: AHR
ISIN Code: GB00BVGBWW93


Trading update for the first half ended 30 September 2025


Assura plc ("Assura"), the UK's leading diversified healthcare REIT, today announces its
Trading Update for the first half to 30 September 2025, in advance of the annual general
meeting being held later today.

Jonathan Murphy, CEO, said:


"I am proud to report on a strong trading performance over the first six months of the financial
year, in what was a period of uncertainty for the business. This is testament to the hard work
and dedication of our team members, the strength of Assura's business, and the vital role we
play within the UK healthcare infrastructure.


"We have delivered strong rental growth, which has flowed into the positive property valuation
uplift, and have continued to identify opportunities to deliver new healthcare developments for
both the NHS and independent sector.


"There remains critical need for investment in healthcare buildings to enable the provision of
high-quality health services. Assura's specialist team has the skills and expertise to partner
with our customers to meet these needs."


Continued track record of delivery to enhance portfolio value and earnings
' Rent reviews completed in the first half generated:

      o Like-for-like increase of 5.6% on #25.5 million of rent roll reviewed
      o Weighted average annual uplift of 2.9%

' Annual equivalent uplift of 2.7% on OMR reviews, 3.0% on RPI and other
' 15 asset enhancement lease events (renewals, regears and net lettings) completed
  covering #1.0 million of rent roll, adding 11 years on average to those leases
' Commenced roll out of rooftop solar commercialisation project

      o First installation at Crompton Health Centre in Bolton fully energised and moving
         on site with a further 10 sites by December

      o Each installation will generate a significant reduction in carbon emissions, reduce
         energy costs for tenants and generate an attractive investment yield
      o Total spend on the first projects is expected to be #1 million, with a pipeline of
         further 40 future schemes now under detailed review

Ongoing development activity

' Construction underway on a #18 million primary care scheme in Weston-Super-Mare pre-
  let to the NHS on a 25 year lease subject to 5 yearly CPIH rent reviews. This is the first
  development funded through the #250 million joint venture with USS

'   Construction to commence shortly on a new #19 million independent hospital in
    Peterborough pre-let to a tier one independent health provider on a 25 year lease subject
    to 3 yearly RPI rent reviews

'   Agreements to commence #7 million extension on two existing independent hospital sites
    to provide further on-site clinical capacity

'   Three existing on site developments in Ireland continue to progress well (total cost #31
    million of which #17 million has been spent to date)


Attractive pipeline of opportunities to support health care system

' #250 million development pipeline capable of commencing in the next 2 years
        o #160 million of large independent sector projects
        o #90 million of NHS primary care schemes

' 31 asset enhancement lease events covering #5.6 million of existing rent roll in the current
    pipeline


Portfolio positioned to deliver strong future cash flows

' Portfolio now stands at 602 properties with an annualised rent roll of #179.5 million (March
   2025: 603. #177.9 million) and a WAULT of 12.3 years (March 2025: 12.7 years)
' Following active portfolio management, portfolio rent reviews consist of: c.54% OMR,
   c.46% indexed, fixed or other

' Highest-ever admissions into the independent sector generating record growth in our
   private hospitals operational profitability, improving rent cover to 2.6x from 2.3x
' Portfolio management activities and rent reviews have contributed to valuation uplift of
   approximately #12 million in the first half. Portfolio Net Initial Yield 5.23% (March 2025:
   5.21%)


Primary Health Properties PLC ("PHP") offer for Assura and delisting from the London
Stock Exchange ("LSE") and Johannesburg Stock Exchange ("JSE")

On 5 September 2025, at the request of PHP, Assura made requests to the FCA and the
London Stock Exchange respectively to cancel the listing and trading of the Assura Shares on
the Equity Shares (Commercial Companies) category of the Official List and Main Market of
the LSE (the "LSE Delisting"). It is anticipated that the LSE Delisting will take effect no earlier
than 7.30 a.m. on 6 October 2025.


Trading of Assura's Shares on the Main Board of the JSE is expected to be suspended from
7.30 a.m. (South African Standard Time) on 3 October 2025. The cancellation of the listing
and trading of the Assura Shares on the Main Board of the JSE is expected to take place on
23 October 2025.


Please refer the announcements on Assura's website for further information on the delisting
and offer from PHP.


                                            ' Ends '



For more information, please contact:

Assura plc                                          Tel: 0161 515 2043
Jayne Cottam, CFO                                   Email: Investor@assura.co.uk
David Purcell, Investor Relations Director


FGS Global                                          Tel: 0207 251 3801
Gordon Simpson                                      Email: Assura-LON@fgsglobal.com
Grace Whelan



Notes to Editors


Assura plc is the UK's leading diversified healthcare REIT. Assura enables better health
outcomes through its portfolio of more than 600 healthcare buildings, from which over six
million patients are served.


A UK REIT based in Altrincham, Assura is currently a constituent of the EPRA* index and has
a secondary listing on the Johannesburg Stock Exchange. As at 31 March 2025, Assura's
portfolio was valued at #3.1 billion and has a strong track record of growing financial returns
and dividends for shareholders.


At Assura we BUILD for health and as a certified B Corp we are committed to keeping ESG
as the heart of our strategy, creating Healthy Environments (E), Healthy Communities (S) and
maintaining a Healthy Business (G).


Further information is available at www.assuraplc.com


*EPRA is a registered trademark of the European Public Real Estate Association
CPIH is Consumer Prices Index including owner occupiers' housing costs



30 September 2025

JSE Sponsor


Nedbank Corporate and Investment Banking, a division of Nedbank Limited

Date: 30-09-2025 08:00:00

Supplied by www.sharenet.co.za                     
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.